{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:03:25Z","timestamp":1785776605625,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41375-025-02835-9","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:49:54Z","timestamp":1766126994000},"page":"444-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Etiology of TP53 mutated complex karyotype acute myeloid leukemia"],"prefix":"10.1038","volume":"40","author":[{"given":"Anna","family":"Fedenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-2855","authenticated-orcid":false,"given":"Honorata","family":"Czapinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-5332","authenticated-orcid":false,"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Bochtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-4463","authenticated-orcid":false,"given":"Matthias","family":"Bochtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2835_CR1","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1038\/bcj.2015.114","volume":"6","author":"F St\u00f6lzel","year":"2016","unstructured":"St\u00f6lzel F, Mohr B, Kramer M, Oelschl\u00e4gel U, Bochtler T, Berdel WE, et al. Karyotype complexity and prognosis in acute myeloid leukemia. Blood Cancer J. 2016;6:e386.","journal-title":"Blood Cancer J"},{"key":"2835_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"2835_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.seminoncol.2008.04.007","volume":"35","author":"K Mr\u00f3zek","year":"2008","unstructured":"Mr\u00f3zek K. Acute Myeloid Leukemia with a Complex Karyotype. Semin Oncol. 2008;35:365.","journal-title":"Semin Oncol"},{"key":"2835_CR4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Cancer Genome Atlas Research Network, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med"},{"key":"2835_CR5","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","volume":"6","author":"OK Weinberg","year":"2022","unstructured":"Weinberg OK, Siddon A, Madanat YF, Gagan J, Arber DA, Dal Cin P, et al. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML. Blood Adv. 2022;6:2847\u201353.","journal-title":"Blood Adv"},{"key":"2835_CR6","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","volume":"119","author":"FG R\u00fccker","year":"2012","unstructured":"R\u00fccker FG, Schlenk RF, Bullinger L, Kayser S, Teleanu V, Kett H, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood. 2012;119:2114\u201321.","journal-title":"Blood"},{"key":"2835_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.59","volume":"5","author":"H-A Hou","year":"2015","unstructured":"Hou H-A, Chou W-C, Kuo Y-Y, Liu C-Y, Lin L-I, Tseng M-H, et al. TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution. Blood Cancer J. 2015;5:e331.","journal-title":"Blood Cancer J"},{"key":"2835_CR8","doi-asserted-by":"crossref","unstructured":"Mr\u00f3zek K, Bloomfield CD. Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia. J Natl Cancer Inst Monogr. 2008;2008:52\u20137.","DOI":"10.1093\/jncimonographs\/lgn003"},{"key":"2835_CR9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2016-09-738161","volume":"129","author":"T Bochtler","year":"2017","unstructured":"Bochtler T, Granzow M, St\u00f6lzel F, Kunz C, Mohr B, Kartal-Kaess M, et al. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia. Blood. 2017;129:1333\u201342.","journal-title":"Blood"},{"key":"2835_CR10","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1158\/2159-8290.CD-22-0332","volume":"12","author":"NG Daver","year":"2022","unstructured":"Daver NG, Maiti A, Kadia TM, Vyas P, Majeti R, Wei AH, et al. TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. Cancer Discov. 2022;12:2516\u201329.","journal-title":"Cancer Discov"},{"key":"2835_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/hemato3040050","volume":"3","author":"F Zingarelli","year":"2022","unstructured":"Zingarelli F, Zannoni L, Curti A. TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective. Hemato. 2022;3:742\u201357.","journal-title":"Hemato"},{"key":"2835_CR12","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41375-019-0390-3","volume":"33","author":"K Mr\u00f3zek","year":"2019","unstructured":"Mr\u00f3zek K, Eisfeld A-K, Kohlschmidt J, Carroll AJ, Walker CJ, Nicolet D, et al. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. Leukemia. 2019;33:1620\u201334.","journal-title":"Leukemia"},{"key":"2835_CR13","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432650","volume":"44","author":"V Santini","year":"2024","unstructured":"Santini V, Stahl M, Sallman DA. TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2024;44:e432650.","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"key":"2835_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41375-023-01845-9","volume":"37","author":"R Bomben","year":"2023","unstructured":"Bomben R, Rossi FM, Vit F, Bittolo T, Zucchetto A, Papotti R, et al. Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study. Leukemia. 2023;37:914\u20138.","journal-title":"Leukemia"},{"key":"2835_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.76","volume":"7","author":"M Chin","year":"2017","unstructured":"Chin M, Sive JI, Allen C, Roddie C, Chavda SJ, Smith D, et al. Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival. Blood Cancer J. 2017;7:e610.","journal-title":"Blood Cancer J"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02835-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:56:04Z","timestamp":1770274564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02835-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02835-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All patients gave informed consent to collect and share clinical material. Ethical board approval has been obtained in accordance with the Declaration of Helsinki (Ethics permits EK 98032010 from the Faculty of Medicine Carl Gustav Carus, Technical University in Dresden, and S-206\/2011 from the Medical Faculty of the University of Heidelberg).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}